Literature DB >> 2917940

Surfactant subtypes in mice: characterization and quantitation.

N J Gross1, K R Narine.   

Abstract

Surfactant obtained by bronchoalveolar lavage of normal adult mice was separated into subtypes by a one-step centrifugation to equilibrium on continuous sucrose gradients. Mouse surfactant resolved in this way exists in three subtypes with similar phospholipid compositions. A "light" subtype of buoyant density 1.027 +/- 0.012 (SD) g/ml comprises 43 +/- 18% of the total alveolar lavage phospholipid, has little surface activity, and consists exclusively of small unilamellar vesicles. A "heavy" subtype of buoyant density 1.055 +/- 0.016 g/ml comprises 48 +/- 11% of the total, is surface active, and consists of small amounts of tubular myelin among large empty vesicles. A third component, called "ultraheavy," comprises 9 +/- 4% of the total alveolar lavage phospholipid, has a density of 1.072 +/- 0.020 g/ml, is surface active, and consists of large aggregates of tubular myelin associated with lamellar bodylike structures. Labeling studies suggested that the ultraheavy material was labeled first and was of the same density as purified lamellar bodies. These results are consistent with the view that, in mice, surfactant is secreted into the alveolar compartment in an ultraheavy form, which evolves into the heavy and light forms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917940     DOI: 10.1152/jappl.1989.66.1.342

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  16 in total

Review 1.  Toxic oxidant species and their impact on the pulmonary surfactant system.

Authors:  E Putman; L M van Golde; H P Haagsman
Journal:  Lung       Date:  1997       Impact factor: 2.584

2.  Surface tension in situ in flooded alveolus unaltered by albumin.

Authors:  Angana Banerjee Kharge; You Wu; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2014-06-26

Review 3.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

4.  Ozone stress initiates acute perturbations of secreted surfactant membranes.

Authors:  J U Balis; J F Paterson; J M Lundh; E M Haller; S A Shelley; M R Montgomery
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

5.  An anionic phospholipid enables the hydrophobic surfactant proteins to alter spontaneous curvature.

Authors:  Mariya Chavarha; Ryan W Loney; Shankar B Rananavare; Stephen B Hall
Journal:  Biophys J       Date:  2013-02-05       Impact factor: 4.033

6.  Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.

Authors:  Philipp Markart; Clemens Ruppert; Malgorzata Wygrecka; Thorsten Colaris; Bhola Dahal; Dieter Walmrath; Heinz Harbach; Jochen Wilhelm; Werner Seeger; Reinhold Schmidt; Andreas Guenther
Journal:  Thorax       Date:  2007-02-07       Impact factor: 9.139

7.  Effects of smoke inhalation on alveolar surfactant subtypes in mice.

Authors:  M R Oulton; D T Janigan; J M MacDonald; G T Faulkner; J E Scott
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

Review 8.  Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.

Authors:  Nashwa El-Gendy; Anubhav Kaviratna; Cory Berkland; Prajnaparamita Dhar
Journal:  Ther Deliv       Date:  2013-08

Review 9.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

10.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.